Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study on the Safety, Tolerability, and Pharmacokinetics of NTX-083 in Healthy Subjects

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 5a9a0aa8b05f5b1c62b1b563578f79abb48968b0
First added on: Apr 24, 2026